Omeprazole maintenance therapy prevents recurrent ulcer bleeding after surgery for duodenal ulcer

World J Gastroenterol. 2006 Feb 7;12(5):791-5. doi: 10.3748/wjg.v12.i5.791.

Abstract

Aim: To evaluate the omeprazole maintenance therapy in patients with recurrent ulcer bleeding after surgery for duodenal ulcer.

Methods: We studied 15 consecutive patients with recurrent ulcer bleeding after surgery for duodenal ulcer. Omeprazole (20 mg/d) maintenance therapy was given after ulcer healing. In addition to clinical follow-up, ambulatory 24-h gastric pH assay was performed before and during omeprazole therapy in those patients and controls with previous duodenal ulcer surgery but no ulcer recurrence.

Results: All the 15 ulcers were healed after being treated with omeprazole (40 mg/d) for 2 mo. Eleven patients with two (1-9) episodes of recurrent ulcer bleeding completed the follow-up (43, 12-72 mo). None of them had a bleeding episode while on omeprazole. One patient discontinued the therapy and had recurrent bleeding. The median 24-h fraction time of gastric pH<4 in patients was 80, 46-95%, and was reduced to 32, 13-70% by omeprazole (P=0.002).

Conclusion: Long-term maintenance therapy with omeprazole (20 mg/day) is effective in preventing recurrent ulcer bleeding.

MeSH terms

  • Aged
  • Anti-Ulcer Agents / therapeutic use*
  • Duodenal Ulcer / drug therapy*
  • Duodenal Ulcer / surgery
  • Gastric Juice / metabolism
  • Humans
  • Hydrogen-Ion Concentration
  • Male
  • Middle Aged
  • Omeprazole / therapeutic use*
  • Peptic Ulcer Hemorrhage / drug therapy*
  • Peptic Ulcer Hemorrhage / prevention & control
  • Peptic Ulcer Hemorrhage / surgery
  • Prospective Studies
  • Recurrence

Substances

  • Anti-Ulcer Agents
  • Omeprazole